Shareholders of Bausch & Lomb Inc approved a proposed $3.67 billion takeover by private equity firm Warburg Pincus on Friday, the eye care company said.
Over two-thirds of the total shares outstanding voted in favor of the deal, which is expected to close early in the fourth quarter, the company said.
In May, Bausch & Lomb agreed to be acquired by Warburg Pincus and had urged shareholders to support the deal. In August, rival Advanced Medical Optics Inc withdrew its $4.23 billion unsolicited takeover bid for the company.
Last week, Bausch & Lomb said that U.S. health regulators had approved its Boston XO2 gas permeable contact lens material for daily wear in patients with ametropia and certain irregular corneal conditions.